Erasca (ERAS) Inks Deal With Pfizer for Colorectal Cancer Study

Published on September 9, 2021

Erasca (ERAS) signs an agreement with Pfizer for a clinical study, which will evaluate ERAS-007 in combination with encorafenib and cetuximab for BRAF...

Continue reading on website
Other news

Humana (HUM), Curant Health Team Up to Aid Chronic Patients

September 9, 2021
Humana (HUM) inks a deal with Curant Health to offer its members with chronic diseases enriched healthcare facilities.

Did the pandemic make you an entrepreneur? Participate in the Startup Grind to leverage your business

September 9, 2021
This is the only conference in Latin America focused exclusively on startup founders and their investors.